PPIB and coronary artery disorder: Given that cyclophilin is known to be secreted from monocytes and vascular wall cells in conditions of oxidative stress such as hyperglycemia, the plasma circulating levels of cyclophilin A in patients with diabetes and CAD possibly reflects an increased oxidative stress and proinflammatory status in these conditions.